Award
National Institute on Aging 5F31AG089990-02
Validating PLCG2 as a target for the treatment of Alzheimer's Disease through cell biology and pharmacological tools
Recipient
Not Specified
Award Amount
$35,608.00
Ceiling
$35,608.00
Awarded
August 05, 2025
Identifier
5F31AG089990-02
Award for research validating PLCG2 as a target for Alzheimer's Disease treatment using cell biology and pharmacological methods.
Description
This project aims to validate PLCG2 as a therapeutic target for Alzheimer's Disease by studying its variants and effects on microglia, using cell biology and pharmacological tools. The award is part of NIH's efforts to support research in neurodegenerative diseases.